Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

359 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Germline homozygosity and allelic imbalance of HLA-I are common in esophagogastric adenocarcinoma and impair the repertoire of immunogenic peptides.
Garcia-Marquez MA, Thelen M, Bauer E, Maas L, Wennhold K, Lehmann J, Keller D, Nikolić M, George J, Zander T, Schröder W, Müller P, Yazbeck AM, Bruns C, Thomas R, Gathof B, Quaas A, Peifer M, Hillmer AM, von Bergwelt-Baildon M, Schlößer HA. Garcia-Marquez MA, et al. Among authors: zander t. J Immunother Cancer. 2024 Apr 17;12(4):e007268. doi: 10.1136/jitc-2023-007268. J Immunother Cancer. 2024. PMID: 38631707 Free PMC article.
Impact of FAPI-46/dual-tracer PET/CT imaging on radiotherapeutic management in esophageal cancer.
Wegen S, Claus K, Linde P, Rosenbrock J, Trommer M, Zander T, Tuchscherer A, Bruns C, Schlößer HA, Schröder W, Eich ML, Fischer T, Schomäcker K, Drzezga A, Kobe C, Sabine Roth K, Weindler JJ. Wegen S, et al. Among authors: zander t. Radiat Oncol. 2024 Apr 4;19(1):44. doi: 10.1186/s13014-024-02430-9. Radiat Oncol. 2024. PMID: 38575990 Free PMC article.
Correlation of primary tumor volume and histopathologic response following neoadjuvant treatment of esophageal adenocarcinoma.
Bremm J, Brunner S, Celik E, Damanakis A, Schlösser H, Fuchs HF, Schmidt T, Zander T, Maintz D, Bruns CJ, Quaas A, Pinto Dos Santos D, Schroeder W. Bremm J, et al. Among authors: zander t. Eur J Surg Oncol. 2024 Apr;50(4):108003. doi: 10.1016/j.ejso.2024.108003. Epub 2024 Feb 11. Eur J Surg Oncol. 2024. PMID: 38401351 Free article.
First-Line Nivolumab Plus Chemotherapy for Advanced Gastric, Gastroesophageal Junction, and Esophageal Adenocarcinoma: 3-Year Follow-Up of the Phase III CheckMate 649 Trial.
Janjigian YY, Ajani JA, Moehler M, Shen L, Garrido M, Gallardo C, Wyrwicz L, Yamaguchi K, Cleary JM, Elimova E, Karamouzis M, Bruges R, Skoczylas T, Bragagnoli A, Liu T, Tehfe M, Zander T, Kowalyszyn R, Pazo-Cid R, Schenker M, Feeny K, Wang R, Lei M, Chen C, Nathani R, Shitara K. Janjigian YY, et al. Among authors: zander t. J Clin Oncol. 2024 Feb 21:JCO2301601. doi: 10.1200/JCO.23.01601. Online ahead of print. J Clin Oncol. 2024. PMID: 38382001
German, Austrian, and Swiss guidelines for systemic treatment of gastric cancer.
Lordick F, Al-Batran SE, Arnold D, Borner M, Bruns CJ, Eisterer W, Faber G, Gockel I, Köberle D, Lorenzen S, Möhler M, Pritzkuleit R, Stahl M, Thuss-Patience P, Wöll E, Zander T, Maschmeyer G; Germany Society of Hematology and Medical Oncology (DGHO, Austrian Society of Hematology and Oncology (OeGHO), Swiss Society of Hematology (SSH), Swiss Society of Medical Oncology (SGMO); in collaboration with the Arbeitsgemeinschaft Internistische Onkologie (AIO) of the German Cancer Society. Lordick F, et al. Among authors: zander t. Gastric Cancer. 2024 Jan;27(1):6-18. doi: 10.1007/s10120-023-01424-y. Epub 2023 Oct 17. Gastric Cancer. 2024. PMID: 37847333 Free PMC article.
359 results